organic compounds
5-Chloro-1-phenylpentan-1-one
aInstitut für Radiopharmazeutische Krebsforschung, Helmholtz-Zentrum Dresden-Rossendorf e.V., Postfach 51 01 19, D-01314 Dresden, Germany, bDepartment of Chemistry and Food Chemistry, Technische Universität Dresden, D-01062 Dresden, Germany, and cUniversität Rostock, Institut für Chemie, Anorganische Festkörperchemie, Albert-Einstein-Strasse 3a, D-18059 Rostock, Germany
*Correspondence e-mail: martin.koeckerling@uni-rostock.de
In the title compound, C11H13ClO, which is used as a starting material for the synthesis of some materials with possible medical applications, the molecular skeleton is slightly curved, with the dihedral angle of 4.7 (1)° between the mean planes of the chlorobutane and benzaldehyde fragments. In the crystal, weak C—H⋯O hydrogen bonds link the molecules into chains running along the [201] direction, and weak C—H⋯π interactions link these chains into layers parallel to the ac plane.
Keywords: crystal structure; δ-chlorobutyl phenyl ketone; hyrogen bonding.
CCDC reference: 1446638
Structure description
The synthesis of the title compound, (I), was previously described in the preparation of building blocks for the synthesis of ω-phenylalkylpyrimidines and purines (Komissarov et al. 2010; Gromov et al. 1999). Another application is the use as coupling component for the synthesis of acyclic triaryl which were described as selective cyclooxygenase-2 inhibitors (Abdellatif et al., 2010, 2011; Uddin et al. 2004a,b) and selective estrogen receptor modulators (Chen et al., 2012; Shiina et al. 2007). In our study, (I) was obtained as product of the reaction of 5-chlorovaleryl chloride with benzene in the presence of aluminium chloride via Friedel–Crafts acylation.
The molecule of (I) (Fig. 1) is nearly flat, but not completely planar - the two mean planes formed by the chlorobutane (Cl1/C1–C4) fragment and by the rest of non-H atoms, respectively, are inclined to each other by 4.7 (1)°. In the crystal, weak C—H⋯O hydrogen bonds (Table 1) link the molecules into chains running along [201]. Weak C—H⋯π interactions (Table 1) link these chains into layers parallel to the ac plane. stabilize further the crystal packing (Fig. 2).
Synthesis and crystallization
To an ice-cold suspension of aluminium chloride (1.76 g, 13.23 mmol) in 10 ml chloroform, 1.86 ml 5-chlorovaleryl chloride (14.40 mmol) and 0.99 ml benzene (11.54 mmol) were added under an argon atmosphere. After stirring for 1.5 h at room temperature, the reaction mixture was poured into a mixture of ice and water (15 ml). The organic layer was separated and washed three times with water (10 ml). The separated aqueous solution was extracted three times with CHCl3 (15 ml), the combined organic layer was dried over Na2SO4 and the solvent was removed under vacuum. After purification with semi-preparative HPLC (ProStar; Varian; microsorb 60, C18; water/acetonitrile + 0.1% TFA; 35 min: 5/5, v/v; 7 ml min−1). 5-Chloro-1-phenylpentan-1-one was obtained as a yellow solid in 91.6% yield. Colorless crystals were obtained by crystallization from acetonitrile/water + 0.1% TFA after chromatographic separation.
Refinement
Crystal data, data collection and structure .
details are summarized in Table 2Structural data
CCDC reference: 1446638
10.1107/S2414314616000559/cv4001sup1.cif
contains datablock I. DOI:Structure factors: contains datablock I. DOI: 10.1107/S2414314616000559/cv4001Isup2.hkl
Supporting information file. DOI: 10.1107/S2414314616000559/cv4001Isup3.cml
To an ice-cold suspension of aluminium chloride (1.76 g, 13.23 mmol) in 10 ml chloroform, 1.86 ml 5-chlorovaleryl chloride (14.40 mmol) and 0.99 ml benzene (11.54 mmol) were added under an argon atmosphere. After stirring for 1.5 h at room temperature, the reaction mixture was poured into a mixture of ice and water (15 ml). The organic layer was separated and washed three times with water (10 ml). The separated aqueous solution was extracted three times with CHCl3 (15 ml), the combined organic layer was dried over Na2SO4 and the solvent was removed under vacuum. After purification with semi-preparative HPLC (ProStar; Varian; microsorb 60, C18; water/acetonitrile + 0.1% TFA; 35 min: 5/5, v/v; 7 ml min−1) 5-chloro-1-phenylpentan-1-one was obtained as a yellow solid in 91.6% yield. Colorless crystals were obtained by crystallization from acetonitrile/water + 0.1% TFA after chromatographic separation.
The synthesis of the title compound, (I), was previously described in the preparation of building blocks for the synthesis of ω-phenylalkylpyrimidines and purines (Komissarov et al. 2010; Gromov et al. 1999). Another application is the use as coupling component for the synthesis of acyclic triaryl which were described as selective cyclooxygenase-2 inhibitors (Abdellatif et al., 2010, 2011; Uddin et al. 2004a,b) and selective estrogen receptor modulators (Chen et al., 2012; Shiina et al. 2007). In our study, (I) was obtained as product of the reaction of 5-chlorovaleryl chloride with benzene in the presence of aluminium chloride via Friedel–Crafts acylation.
The molecule of (I) (Fig. 1) is nearly flat, but not completely planar - two mean planes formed by the chlorobutane (Cl1/C1–C4) fragment and by the rest of non-H atoms, respectively, are inclined to each other by 4.7 (1)°. In the crystal, weak C—H···O hydrogen bonds (Table 1) link the molecules into chains running along [201]. Weak C—H···π interactions (Table 1) link these chains into layers parallel to the ac plane. stabilize further the crystal packing (Fig. 2).
Data collection: APEX2 (Bruker, 2007); cell
SAINT (Bruker, 2007); data reduction: SAINT (Bruker, 2007); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).Fig. 1. The molecular structure of (I), with atom labels and 50% probability displacement ellipsoids for non-H atoms. | |
Fig. 2. A portion of the crystal packing, viewed approximately along the a axis. |
C11H13ClO | Dx = 1.291 Mg m−3 |
Mr = 196.66 | Melting point = 320–321 K |
Monoclinic, P21/c | Mo Kα radiation, λ = 0.71073 Å |
a = 5.2434 (4) Å | Cell parameters from 1422 reflections |
b = 25.902 (2) Å | θ = 2.9–22.7° |
c = 7.7027 (6) Å | µ = 0.33 mm−1 |
β = 104.756 (5)° | T = 173 K |
V = 1011.6 (1) Å3 | Irregular block, colorless |
Z = 4 | 0.32 × 0.27 × 0.26 mm |
F(000) = 416 |
Bruker APEXII CCD diffractometer | 2343 independent reflections |
Radiation source: sealed tube | 1411 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.042 |
φ and ω scans | θmax = 27.6°, θmin = 1.6° |
Absorption correction: multi-scan (SADABS; Bruker, 2007) | h = −6→5 |
k = −33→29 | |
9116 measured reflections | l = −10→10 |
Refinement on F2 | Secondary atom site location: difference Fourier map |
Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
R[F2 > 2σ(F2)] = 0.043 | H-atom parameters constrained |
wR(F2) = 0.108 | w = 1/[σ2(Fo2) + (0.0362P)2 + 0.2948P] where P = (Fo2 + 2Fc2)/3 |
S = 1.01 | (Δ/σ)max < 0.001 |
2343 reflections | Δρmax = 0.22 e Å−3 |
119 parameters | Δρmin = −0.31 e Å−3 |
0 restraints | Extinction correction: SHELXL2014 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4 |
Primary atom site location: structure-invariant direct methods | Extinction coefficient: 0.0021 (13) |
C11H13ClO | V = 1011.6 (1) Å3 |
Mr = 196.66 | Z = 4 |
Monoclinic, P21/c | Mo Kα radiation |
a = 5.2434 (4) Å | µ = 0.33 mm−1 |
b = 25.902 (2) Å | T = 173 K |
c = 7.7027 (6) Å | 0.32 × 0.27 × 0.26 mm |
β = 104.756 (5)° |
Bruker APEXII CCD diffractometer | 2343 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2007) | 1411 reflections with I > 2σ(I) |
Rint = 0.042 | |
9116 measured reflections |
R[F2 > 2σ(F2)] = 0.043 | 0 restraints |
wR(F2) = 0.108 | H-atom parameters constrained |
S = 1.01 | Δρmax = 0.22 e Å−3 |
2343 reflections | Δρmin = −0.31 e Å−3 |
119 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.30681 (13) | 0.47935 (2) | 0.72353 (9) | 0.0622 (2) | |
C1 | 0.0779 (4) | 0.42960 (8) | 0.6269 (3) | 0.0403 (5) | |
H1A | −0.0813 | 0.4326 | 0.6731 | 0.048* | |
H1B | 0.0231 | 0.4340 | 0.4949 | 0.048* | |
C2 | 0.1990 (4) | 0.37676 (7) | 0.6714 (2) | 0.0330 (5) | |
H2A | 0.2507 | 0.3722 | 0.8033 | 0.040* | |
H2B | 0.3602 | 0.3741 | 0.6274 | 0.040* | |
C3 | 0.0082 (4) | 0.33416 (8) | 0.5870 (2) | 0.0335 (5) | |
H3A | −0.0485 | 0.3395 | 0.4555 | 0.040* | |
H3B | −0.1503 | 0.3360 | 0.6342 | 0.040* | |
C4 | 0.1323 (4) | 0.28088 (7) | 0.6257 (2) | 0.0311 (5) | |
H4A | 0.2869 | 0.2788 | 0.5744 | 0.037* | |
H4B | 0.1961 | 0.2763 | 0.7573 | 0.037* | |
C5 | −0.0547 (4) | 0.23775 (8) | 0.5504 (2) | 0.0322 (5) | |
O1 | −0.2751 (3) | 0.24672 (6) | 0.4561 (2) | 0.0515 (4) | |
C6 | 0.0313 (4) | 0.18322 (8) | 0.5912 (2) | 0.0286 (4) | |
C7 | −0.1480 (4) | 0.14405 (8) | 0.5232 (2) | 0.0342 (5) | |
H7 | −0.3185 | 0.1527 | 0.4514 | 0.041* | |
C8 | −0.0816 (4) | 0.09289 (8) | 0.5587 (3) | 0.0395 (5) | |
H8 | −0.2066 | 0.0665 | 0.5128 | 0.047* | |
C9 | 0.1679 (4) | 0.07998 (8) | 0.6614 (3) | 0.0386 (5) | |
H9 | 0.2143 | 0.0448 | 0.6855 | 0.046* | |
C10 | 0.3486 (4) | 0.11831 (8) | 0.7284 (3) | 0.0352 (5) | |
H10 | 0.5196 | 0.1093 | 0.7983 | 0.042* | |
C11 | 0.2830 (4) | 0.16993 (8) | 0.6946 (2) | 0.0307 (5) | |
H11 | 0.4085 | 0.1961 | 0.7416 | 0.037* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0628 (5) | 0.0355 (4) | 0.0776 (5) | 0.0012 (3) | −0.0018 (3) | 0.0025 (3) |
C1 | 0.0395 (12) | 0.0400 (13) | 0.0373 (11) | 0.0058 (10) | 0.0023 (9) | 0.0023 (9) |
C2 | 0.0318 (11) | 0.0358 (12) | 0.0297 (10) | 0.0081 (9) | 0.0044 (8) | 0.0026 (9) |
C3 | 0.0306 (11) | 0.0396 (12) | 0.0283 (10) | 0.0074 (9) | 0.0040 (8) | 0.0010 (9) |
C4 | 0.0279 (10) | 0.0366 (12) | 0.0276 (9) | 0.0028 (9) | 0.0045 (8) | 0.0003 (8) |
C5 | 0.0270 (11) | 0.0430 (13) | 0.0257 (10) | 0.0004 (9) | 0.0049 (8) | −0.0009 (9) |
O1 | 0.0338 (9) | 0.0503 (10) | 0.0572 (10) | 0.0034 (8) | −0.0125 (7) | 0.0044 (8) |
C6 | 0.0267 (10) | 0.0379 (12) | 0.0214 (9) | −0.0013 (9) | 0.0064 (8) | −0.0006 (8) |
C7 | 0.0283 (11) | 0.0438 (13) | 0.0294 (10) | −0.0034 (10) | 0.0051 (8) | −0.0007 (9) |
C8 | 0.0358 (12) | 0.0437 (14) | 0.0397 (11) | −0.0112 (10) | 0.0106 (10) | −0.0052 (10) |
C9 | 0.0423 (13) | 0.0343 (13) | 0.0418 (12) | 0.0003 (10) | 0.0153 (10) | 0.0009 (10) |
C10 | 0.0306 (11) | 0.0391 (13) | 0.0354 (11) | 0.0046 (10) | 0.0076 (9) | 0.0020 (9) |
C11 | 0.0248 (10) | 0.0371 (12) | 0.0287 (10) | −0.0013 (9) | 0.0042 (8) | −0.0021 (8) |
Cl1—C1 | 1.789 (2) | C5—O1 | 1.221 (2) |
C1—C2 | 1.511 (3) | C5—C6 | 1.491 (3) |
C1—H1A | 0.9900 | C6—C7 | 1.392 (3) |
C1—H1B | 0.9900 | C6—C11 | 1.400 (2) |
C2—C3 | 1.520 (3) | C7—C8 | 1.380 (3) |
C2—H2A | 0.9900 | C7—H7 | 0.9500 |
C2—H2B | 0.9900 | C8—C9 | 1.386 (3) |
C3—C4 | 1.522 (3) | C8—H8 | 0.9500 |
C3—H3A | 0.9900 | C9—C10 | 1.379 (3) |
C3—H3B | 0.9900 | C9—H9 | 0.9500 |
C4—C5 | 1.502 (3) | C10—C11 | 1.389 (3) |
C4—H4A | 0.9900 | C10—H10 | 0.9500 |
C4—H4B | 0.9900 | C11—H11 | 0.9500 |
C2—C1—Cl1 | 111.07 (14) | H4A—C4—H4B | 107.7 |
C2—C1—H1A | 109.4 | O1—C5—C6 | 119.69 (18) |
Cl1—C1—H1A | 109.4 | O1—C5—C4 | 120.95 (19) |
C2—C1—H1B | 109.4 | C6—C5—C4 | 119.36 (16) |
Cl1—C1—H1B | 109.4 | C7—C6—C11 | 118.92 (18) |
H1A—C1—H1B | 108.0 | C7—C6—C5 | 118.17 (17) |
C1—C2—C3 | 111.59 (16) | C11—C6—C5 | 122.92 (17) |
C1—C2—H2A | 109.3 | C8—C7—C6 | 120.89 (18) |
C3—C2—H2A | 109.3 | C8—C7—H7 | 119.6 |
C1—C2—H2B | 109.3 | C6—C7—H7 | 119.6 |
C3—C2—H2B | 109.3 | C7—C8—C9 | 119.90 (19) |
H2A—C2—H2B | 108.0 | C7—C8—H8 | 120.0 |
C2—C3—C4 | 111.86 (15) | C9—C8—H8 | 120.0 |
C2—C3—H3A | 109.2 | C10—C9—C8 | 119.9 (2) |
C4—C3—H3A | 109.2 | C10—C9—H9 | 120.0 |
C2—C3—H3B | 109.2 | C8—C9—H9 | 120.0 |
C4—C3—H3B | 109.2 | C9—C10—C11 | 120.62 (19) |
H3A—C3—H3B | 107.9 | C9—C10—H10 | 119.7 |
C5—C4—C3 | 113.21 (15) | C11—C10—H10 | 119.7 |
C5—C4—H4A | 108.9 | C10—C11—C6 | 119.74 (18) |
C3—C4—H4A | 108.9 | C10—C11—H11 | 120.1 |
C5—C4—H4B | 108.9 | C6—C11—H11 | 120.1 |
C3—C4—H4B | 108.9 |
Cg is the centroid of the C6–C11 benzene ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···O1i | 0.95 | 2.51 | 3.422 (2) | 169 |
C2—H2A···Cgii | 0.99 | 2.80 | 3.676 (2) | 148 |
Symmetry codes: (i) x+1, −y+1/2, z+1/2; (ii) x, −y+1/2, z+1/2. |
Cg is the centroid of the C6–C11 benzene ring. |
D—H···A | D—H | H···A | D···A | D—H···A |
C11—H11···O1i | 0.95 | 2.51 | 3.422 (2) | 169 |
C2—H2A···Cgii | 0.99 | 2.80 | 3.676 (2) | 148 |
Symmetry codes: (i) x+1, −y+1/2, z+1/2; (ii) x, −y+1/2, z+1/2. |
Experimental details
Crystal data | |
Chemical formula | C11H13ClO |
Mr | 196.66 |
Crystal system, space group | Monoclinic, P21/c |
Temperature (K) | 173 |
a, b, c (Å) | 5.2434 (4), 25.902 (2), 7.7027 (6) |
β (°) | 104.756 (5) |
V (Å3) | 1011.6 (1) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.33 |
Crystal size (mm) | 0.32 × 0.27 × 0.26 |
Data collection | |
Diffractometer | Bruker APEXII CCD |
Absorption correction | Multi-scan (SADABS; Bruker, 2007) |
No. of measured, independent and observed [I > 2σ(I)] reflections | 9116, 2343, 1411 |
Rint | 0.042 |
(sin θ/λ)max (Å−1) | 0.652 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.043, 0.108, 1.01 |
No. of reflections | 2343 |
No. of parameters | 119 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.22, −0.31 |
Computer programs: APEX2 (Bruker, 2007), SAINT (Bruker, 2007), SHELXS97 (Sheldrick, 2008), SHELXL2014 (Sheldrick, 2015), SHELXTL (Sheldrick, 2008).
Acknowledgements
Help with the X-ray diffraction experiments by Dr A. Villinger and Dipl.-Chem. P. Thiele (University of Rostock) is gratefully acknowledged.
References
Abdellatif, K. R., Velázquez, C. A., Huang, Z., Chowdhury, M. A. & Knaus, E. E. (2010). Bioorg. Med. Chem. Lett. 20, 5245–5250. CrossRef CAS PubMed Google Scholar
Abdellatif, K. R., Velázquez, C. A., Huang, Z., Chowdhury, M. A. & Knaus, E. E. (2011). Bioorg. Med. Chem. Lett. 21, 1195–1198. CrossRef CAS PubMed Google Scholar
Bruker (2007). APEX2, SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Chen, X. Y., Park, S. J., Buschmann, H., De Rosa, M. & Bolm, C. (2012). Bioorg. Med. Chem. Lett. 22, 4307–4309. CrossRef CAS PubMed Google Scholar
Gromov, M. Y., Skachilova, S. Y., Aleksandrova, E. V. & Kochergin, P. M. (1999). Chem. Heterocycl. Compd. 35, 1225–1229. CrossRef CAS Google Scholar
Komissarov, V. V. & Kritzyn, A. M. (2010). Russ. J. Bioorg. Chem. 36, 477–487. CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Shiina, I., Sano, Y., Nakata, K., Suzuki, M., Yokoyama, T., Sasaki, A., Orikasa, T., Miyamoto, T., Ikekita, M., Nagahara, Y. & Hasome, Y. (2007). Bioorg. Med. Chem. 15, 7599–7617. CrossRef PubMed CAS Google Scholar
Uddin, M. J., Rao, P. N. P. & Knaus, E. E. (2004a). Bioorg. Med. Chem. 12, 5929–5940. CrossRef PubMed CAS Google Scholar
Uddin, M. J., Rao, P. N. P. & Knaus, E. E. (2004b). Bioorg. Med. Chem. Lett. 14, 1953–1956. CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
The synthesis of the title compound, (I), was previously described in the preparation of building blocks for the synthesis of ω-phenylalkylpyrimidines and purines (Komissarov et al. 2010; Gromov et al. 1999). Another application is the use as coupling component for the synthesis of acyclic triaryl olefins, which were described as selective cyclooxygenase-2 inhibitors (Abdellatif et al., 2010, 2011; Uddin et al. 2004a,b) and selective estrogen receptor modulators (Chen et al., 2012; Shiina et al. 2007). In our study, (I) was obtained as product of the reaction of 5-chlorovaleryl chloride with benzene in the presence of aluminium chloride via Friedel-Crafts acylation.
The molecule of (I) (Fig. 1) is nearly flat, but not completely planar - two mean planes formed by the chlorobutane (Cl1/C1—C4) fragment and by the rest of non-H atoms, respectively, are inclined to each other at 4.7 (1)%. In the crystal, weak intermolecular C—H···O hydrogen bonds (Table 1) link the molecules into chains running in [201], and weak C—H···π interactions (Table 1) link these chains into layers parallel to the ac plane. Van der Waals forces stabilize further the crystal packing (Fig. 2).